Diabetic nephropathy future or investigational therapies: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Future or Investigational Therapies== | |||
[[C-peptide]], a by-product of insulin production, may provide new hope for patients sufering from diabetic nephropathy <ref>[http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&list_uids=17235526&cmd=Retrieve&indexed=google C-peptide is a bioactive peptide. [Diabetologia. 2007] - PubMed Result<!-- Bot generated title -->]</ref> <ref>{{cite journal |author=Wahren J, Ekberg K, Jörnvall H |title=C-peptide is a bioactive peptide |journal=Diabetologia |volume=50 |issue=3 |pages=503–9 |year=2007 |pmid=17235526 |doi=10.1007/s00125-006-0559-y |url=}}</ref>. | [[C-peptide]], a by-product of insulin production, may provide new hope for patients sufering from diabetic nephropathy <ref>[http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&list_uids=17235526&cmd=Retrieve&indexed=google C-peptide is a bioactive peptide. [Diabetologia. 2007] - PubMed Result<!-- Bot generated title -->]</ref> <ref>{{cite journal |author=Wahren J, Ekberg K, Jörnvall H |title=C-peptide is a bioactive peptide |journal=Diabetologia |volume=50 |issue=3 |pages=503–9 |year=2007 |pmid=17235526 |doi=10.1007/s00125-006-0559-y |url=}}</ref>. | ||
| Line 9: | Line 11: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Needs overview]] | |||
[[Category:Needs content]] | |||
[[Category:Pediatrics]] | |||
[[Category:Endocrinology]] | |||
[[Category:Nephrology]] | |||
Latest revision as of 19:47, 25 July 2016
|
Diabetic nephropathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Diabetic nephropathy future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Diabetic nephropathy future or investigational therapies |
|
FDA on Diabetic nephropathy future or investigational therapies |
|
CDC on Diabetic nephropathy future or investigational therapies |
|
Diabetic nephropathy future or investigational therapies in the news |
|
Blogs on Diabetic nephropathy future or investigational therapies |
|
Risk calculators and risk factors for Diabetic nephropathy future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]
Overview
Future or Investigational Therapies
C-peptide, a by-product of insulin production, may provide new hope for patients sufering from diabetic nephropathy [1] [2].
References
- ↑ C-peptide is a bioactive peptide. [Diabetologia. 2007] - PubMed Result
- ↑ Wahren J, Ekberg K, Jörnvall H (2007). "C-peptide is a bioactive peptide". Diabetologia. 50 (3): 503–9. doi:10.1007/s00125-006-0559-y. PMID 17235526.